MP-104-CL-022OLE: An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects with Duchenne Muscular Dystrophy IRB #2015-

Project: Research project

Project Details

StatusFinished
Effective start/end date2/27/15 → 2/26/17

Funding

  • Marathon Pharmaceuticals, LLC